secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oscar Health, Inc. (OSCR)
CIK:        0001568651
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001568651-25-000021
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oscar Health Q2 net loss $228.4M, MLR 91.1% vs 79.0% YoY; revenue up 29%
------------------------------------------------------------------------

- Total revenue: $2.86B, up 29% YoY from $2.22B on higher membership, partly offset by risk adjustment accrual.
- Medical loss ratio worsened to 91.1% from 79.0%, driven by higher market morbidity and net risk adjustment accrual.
- Net loss attributable to Oscar of $228.4M ($0.89 per diluted share) vs net income of $56.2M ($0.20) in Q2 2024.
- Adjusted EBITDA loss $199.4M, compared to positive $104.1M a year ago; SG&A ratio improved to 18.7% from 19.6%.
- Reaffirmed full-year 2025 outlook; membership grew 28% to 2.03M; Cigna+Oscar members fell from 58k to 10k.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1568651/000156865125000021/0001568651-25-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1568651/000156865125000021/oscr-20250806.htm
  HTML page:      https://secwatch.observer/filing/0001568651-25-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer